Patient Monitoring Devices Market Size, Growth, Demands Outlook and Forecasts to 2030

According to the research report, the global patientmonitoring devices market size is expected to touch USD 80.75  Billion by 2030, from USD 36.5 Billion in 2021, growing with a significant CAGR of 8.3 % from 2021 to 2030. 

    

The patient monitoring devices report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global patient monitoring devices in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global patient monitoring devices market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global patient monitoring devices during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1288

 Report Scope of the Patient Monitoring Devices Market

Report Coverage	Details
Market Size	USD 80.75 Billion by 2030
Growth Rate	CAGR of 8.3% From 2021 to 2030
Base Year	2020
Historic Data	2017 to 2020
Forecast Period	2021 to 2030
Segments Covered	Product, End User
Regional Scope	North America, APAC, Europe, Latin America, MEAN, Rest of the World

This study covers a detailed segmentation of the global patient monitoring devices market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global patient monitoring devices market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players are  Abbott Laboratories, Hill-Rom Holdings, Inc., Drägerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, OMRON Corporation, Masimo Corporation, Compumedics Limited, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, Natus Medical, Medtronic plc (Ireland), Koninklijke Philips N.V., GE Healthcare, Getinge AB, Boston Scientific Corporation, Dexcom, Inc., Nonin, BIOTRONIK, SCHILLER, and BioTelemetry, Inc

Market Segmentation

 By Product

• Cardiac Monitoring Devices
  • ECG Devices
  • Implantable Loop Recorders
  • Event Monitors
  • Mobile Cardiac Telemetry Monitors
  • Smart/Wearable ECG Monitors
• Blood Glucose Monitoring Systems
  • Self-monitoring Blood Glucose Systems
  • Continuous Glucose Monitoring Systems
• Multi-parameter Monitoring Devices
  • Low-acuity Monitoring Devices
  • Mid-acuity Monitoring Devices
  • High-acuity Monitoring Devices
• Temperature Monitoring Devices
  • Handheld Temperature Monitoring Devices
  • Table-top Temperature Monitoring Devices
  • Wearable Continuous Monitoring Devices
  • Invasive Temperature Monitoring Devices
  • Smart Temperature Monitoring Devices
• Respiratory Monitoring Devices
  • Pulse Oximeters
  • Spirometers
  • Capnographs
  • Peak Flow Meters
• Hemodynamic/Pressure Monitoring Devices
  • Hemodynamic Monitors
  • Blood Pressure Monitors
  • Disposables
• Fetal& Neonatal Monitoring Devices
  • Fetal Monitoring Devices
  • Neonatal Monitoring Devices
• Neuromonitoring Devices
  • Electroencephalograph Machines
  • Electromyography Machines
  • Cerebral Oximeters
  • Intracranial Pressure Monitors
  • Magnetoencephalograph Machines
  • Transcranial Doppler Machines
• Weight Monitoring Devices
  • Digital
  • Analog
• Other Patient Monitoring Devices

By End-use

• Hospitals
• Home Care Settings
• Ambulatory Surgery Centers
• Others

By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• U.K.
• Germany
• France
• Russia
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

• LAMEA
• Latin America
• Middle East
• Africa

Research Methodology

The research methodology adopted by analysts for compiling the global patient monitoring devices report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global patient monitoring devices market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Patient Monitoring Devices Market, By Product

7.1. Patient Monitoring Devices Market, by Product Type, 2021-2030

7.1.1. Cardiac Monitoring Devices

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Blood Glucose Monitoring Systems

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Multi-parameter Monitoring Devices

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Temperature Monitoring Devices

7.1.4.1. Market Revenue and Forecast (2017-2030)

7.1.5. Respiratory Monitoring Devices

7.1.5.1. Market Revenue and Forecast (2017-2030)

7.1.6. Hemodynamic/Pressure Monitoring Devices

7.1.6.1. Market Revenue and Forecast (2017-2030)

7.1.7. Fetal & Neonatal Monitoring Devices

7.1.7.1. Market Revenue and Forecast (2017-2030)

7.1.8. Neuromonitoring Devices

7.1.8.1. Market Revenue and Forecast (2017-2030)

7.1.9. Weight Monitoring Devices

7.1.9.1. Market Revenue and Forecast (2017-2030)

7.1.10. Others

7.1.10.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Patient Monitoring Devices Market, By End-use

8.1. Patient Monitoring Devices Market, by End-use, 2021-2030

8.1.1. Hospitals

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Home Care Settings

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Ambulatory Surgery Centers

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Patient Monitoring Devices Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Product (2017-2030)

9.1.2. Market Revenue and Forecast, by End-use (2017-2030)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.2. Market Revenue and Forecast, by End-use (2017-2030)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

9.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.2. Market Revenue and Forecast, by End-use (2017-2030)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

9.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.2. Market Revenue and Forecast, by End-use (2017-2030)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

9.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Product (2017-2030)

9.5.2. Market Revenue and Forecast, by End-use (2017-2030)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Product (2017-2030)

9.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

9.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 10. Company Profiles

10.1. Abbott Laboratories

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. Hill-Rom Holdings, Inc.

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Drägerwerk AG & Co. KGaA

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Edwards Lifesciences Corporation

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. OMRON Corporation

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Masimo Corporation

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Compumedics Limited

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. Nihon Kohden Corporation

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Natus Medical

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com